IL120718A0 - New applications of 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropypridine-3-carboxylate of 2-[1,2-benzisothiazolyl-3(2H)one-1,1-dioxide] ethyl - Google Patents

New applications of 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropypridine-3-carboxylate of 2-[1,2-benzisothiazolyl-3(2H)one-1,1-dioxide] ethyl

Info

Publication number
IL120718A0
IL120718A0 IL12071896A IL12071896A IL120718A0 IL 120718 A0 IL120718 A0 IL 120718A0 IL 12071896 A IL12071896 A IL 12071896A IL 12071896 A IL12071896 A IL 12071896A IL 120718 A0 IL120718 A0 IL 120718A0
Authority
IL
Israel
Prior art keywords
dihydropypridine
benzisothiazolyl
ethoxycarbonyl
carboxylate
trimethyl
Prior art date
Application number
IL12071896A
Other languages
English (en)
Original Assignee
Alter Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alter Lab filed Critical Alter Lab
Publication of IL120718A0 publication Critical patent/IL120718A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12071896A 1995-08-25 1996-08-20 New applications of 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropypridine-3-carboxylate of 2-[1,2-benzisothiazolyl-3(2H)one-1,1-dioxide] ethyl IL120718A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95500122A EP0771560A1 (en) 1995-08-25 1995-08-25 Use of 2- N-(1,2-benzoisothiazolyl-3(2H)one-1,1-dioxide ethyl 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropiridine-3-carboxylate in the treatment of vascular disorders
PCT/ES1996/000160 WO1997007801A1 (es) 1995-08-25 1996-08-20 Nuevas aplicaciones del 5-etoxicarbonil-2,4,6-trimetil-1,4-dihidropiridina-3-carboxilato de 2-[n-(1,2-benzisotiazolil-3(2h)ona-1,1-dioxido]etilo

Publications (1)

Publication Number Publication Date
IL120718A0 true IL120718A0 (en) 1997-08-14

Family

ID=8221657

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12071896A IL120718A0 (en) 1995-08-25 1996-08-20 New applications of 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropypridine-3-carboxylate of 2-[1,2-benzisothiazolyl-3(2H)one-1,1-dioxide] ethyl

Country Status (12)

Country Link
EP (1) EP0771560A1 (es)
JP (1) JPH10508879A (es)
KR (1) KR970706817A (es)
AU (1) AU6931496A (es)
BR (1) BR9606691A (es)
CA (1) CA2203624A1 (es)
EA (1) EA199700053A1 (es)
HU (1) HUP9701695A3 (es)
IL (1) IL120718A0 (es)
MX (1) MX9703032A (es)
WO (1) WO1997007801A1 (es)
ZA (1) ZA967223B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten

Also Published As

Publication number Publication date
HUP9701695A3 (en) 1999-10-28
CA2203624A1 (en) 1997-03-06
HUP9701695A2 (hu) 1998-03-30
KR970706817A (ko) 1997-12-01
BR9606691A (pt) 2000-05-09
JPH10508879A (ja) 1998-09-02
AU6931496A (en) 1997-03-19
ZA967223B (en) 1997-03-03
WO1997007801A1 (es) 1997-03-06
EA199700053A1 (ru) 1997-12-30
EP0771560A1 (en) 1997-05-07
MX9703032A (es) 1997-12-31

Similar Documents

Publication Publication Date Title
AU4121096A (en) Thickened peracid compositions
PL380733A1 (pl) Pochodne 3, 3-difenylopropyloamin, sposoby ich wytwarzania, ich zastosowanie medyczne oraz kompozycja farmaceutyczna
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
GB9518552D0 (en) New heterocyclic compounds
PL338563A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
AU4121296A (en) Thickened peracid compositions
PL324992A1 (en) Novel derivatives of 2,3-dioxotetrahydoquinoxaline
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
AU4287096A (en) Oral compositions of h2-antagonists
IL134802A0 (en) Oral compositions of levosimendan
AU4329396A (en) Use of 3,4-diphenylchromans
HUP9602510A3 (en) Preparation of substituted thiazoles
PL340372A1 (en) Novel 3,6x-hemiketals of 9a-azalydes class
AU4702496A (en) Oral compositions of h2-antagonists
PL325517A1 (en) Derivatives of benzothiazolone
PL312692A1 (en) New derivatives of dialkoxy-pyridinol-benzimidazole
NO975869D0 (no) Forbedret syntese av 2,4,6,8,10,12-heksabenzyl-2,4,6,8,10,12-heksaazatetracyklo£5,5,0,05,9,03,11|dodecan
IL120718A0 (en) New applications of 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropypridine-3-carboxylate of 2-[1,2-benzisothiazolyl-3(2H)one-1,1-dioxide] ethyl
AU4877696A (en) Use of fused benzothiazoles as neuroprotectants
AU6965398A (en) Preparation of thiazoles using 1,3-dihalopropenes
HU9503736D0 (en) New derivatives of trans apovincaminic-acid-esters
AU6418396A (en) Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-ox-4-aza-5alp ha-androst-1-ene-17beta-carboxamide
IL117813A0 (en) Use of heterocyclic compounds
AU5236096A (en) Ceramic type sunscreens
EP0835517A4 (en) PRODUCTION OF CAPACITORS